ZA200908919B - Pyrazolopyrrolidines as inhibitors of gamma secretase - Google Patents

Pyrazolopyrrolidines as inhibitors of gamma secretase

Info

Publication number
ZA200908919B
ZA200908919B ZA200908919A ZA200908919A ZA200908919B ZA 200908919 B ZA200908919 B ZA 200908919B ZA 200908919 A ZA200908919 A ZA 200908919A ZA 200908919 A ZA200908919 A ZA 200908919A ZA 200908919 B ZA200908919 B ZA 200908919B
Authority
ZA
South Africa
Prior art keywords
pyrazolopyrrolidines
inhibitors
gamma secretase
secretase
gamma
Prior art date
Application number
ZA200908919A
Other languages
English (en)
Inventor
Darren Dressen
Simeon Bowers
Albert W Garofalo
Roy K Hom
Matthew N Mattson
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Publication of ZA200908919B publication Critical patent/ZA200908919B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200908919A 2007-05-25 2009-12-15 Pyrazolopyrrolidines as inhibitors of gamma secretase ZA200908919B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93184007P 2007-05-25 2007-05-25

Publications (1)

Publication Number Publication Date
ZA200908919B true ZA200908919B (en) 2010-08-25

Family

ID=39679310

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200908919A ZA200908919B (en) 2007-05-25 2009-12-15 Pyrazolopyrrolidines as inhibitors of gamma secretase

Country Status (17)

Country Link
US (1) US7977368B2 (es)
EP (1) EP2152713B1 (es)
JP (1) JP2010528036A (es)
AR (1) AR066712A1 (es)
AT (1) ATE523511T1 (es)
AU (1) AU2008256940A1 (es)
BR (1) BRPI0812014A2 (es)
CA (1) CA2687765A1 (es)
CL (1) CL2008001516A1 (es)
CO (1) CO6241122A2 (es)
ES (1) ES2373253T3 (es)
MX (1) MX2009012525A (es)
NZ (1) NZ582039A (es)
PE (1) PE20090280A1 (es)
TW (1) TW200904413A (es)
WO (1) WO2008147800A1 (es)
ZA (1) ZA200908919B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8283358B2 (en) * 2008-09-05 2012-10-09 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds
PL2462118T3 (pl) * 2009-08-03 2014-10-31 Acraf Sposób wytwarzania 1-benzylo-3-hydroksymetylo-1H-indazolu i jego pochodnych oraz potrzebnych magnezowych związków pośrednich
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
US8481541B2 (en) 2010-03-22 2013-07-09 Hoffmann-La Roche Inc. Pyrrolopyrazine kinase inhibitors
US8518945B2 (en) 2010-03-22 2013-08-27 Hoffmann-La Roche Inc. Pyrrolopyrazine kinase inhibitors
JP2013526558A (ja) 2010-05-20 2013-06-24 エフ．ホフマン−ラ ロシュ アーゲー Ｓｙｋ及びｊａｋ阻害剤としてのピロロピラジン誘導体
EP2571880A1 (en) 2010-05-20 2013-03-27 F.Hoffmann-La Roche Ag Pyrrolo [2, 3 - b]pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
JP6644017B2 (ja) * 2017-03-30 2020-02-12 長弘生物科技股▲ふん▼有限公司 ブチリデンフタリドの用途、その使用方法及びそれを使用して医薬組成物を製造する方法
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2207019T3 (es) * 1997-12-27 2004-05-16 Kaneka Corporation Procedimiento para producir acidos beta-halogeno-alfa-amino-carboxilicos y derivados de fenilcisteina y productos intermedios de ellos.
US6887898B1 (en) * 1999-10-22 2005-05-03 Darrick S. H. L. Kim Pharmaceutical compositions useful in prevention and treatment of beta-Amyloid protein-induced disease
US6559174B2 (en) 2001-03-20 2003-05-06 Merck & Co., Inc. N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors
TW200302717A (en) * 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
US20040171614A1 (en) * 2002-02-06 2004-09-02 Schering-Plough Corporation Novel gamma secretase inhibitors
US7256186B2 (en) 2002-02-06 2007-08-14 Schering Corporation Gamma secretase inhibitors
MXPA05000947A (es) * 2002-07-25 2005-05-16 Pharmacia Italia Spa Biciclo-pirazoles activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
US20060264380A1 (en) 2003-07-21 2006-11-23 Mats Hellstrom Compounds and Methods for Promoting Angiogenesis
WO2005030776A1 (en) * 2003-09-23 2005-04-07 Vertex Pharmaceuticals Incorporated Pyrazolopyrrole derivatives as protein kinase inhibitors
MX2008002234A (es) 2005-08-19 2008-03-27 Elan Pharm Inc Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.
EA014906B1 (ru) * 2005-12-01 2011-02-28 Элан Фармасьютикалз, Инк. 5-(арилсульфонил)пиразолопиперидины
UY30377A1 (es) 2006-06-02 2008-01-02 Elan Pharm Inc Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa

Also Published As

Publication number Publication date
US7977368B2 (en) 2011-07-12
NZ582039A (en) 2012-02-24
EP2152713B1 (en) 2011-09-07
WO2008147800A1 (en) 2008-12-04
MX2009012525A (es) 2009-12-09
BRPI0812014A2 (pt) 2014-11-18
AR066712A1 (es) 2009-09-09
CO6241122A2 (es) 2011-01-20
ES2373253T3 (es) 2012-02-01
AU2008256940A1 (en) 2008-12-04
TW200904413A (en) 2009-02-01
ATE523511T1 (de) 2011-09-15
PE20090280A1 (es) 2009-03-19
JP2010528036A (ja) 2010-08-19
US20090099235A1 (en) 2009-04-16
CL2008001516A1 (es) 2008-10-10
EP2152713A1 (en) 2010-02-17
CA2687765A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
ZA201700326B (en) Inhibitors of beta-secretase
ZA200906946B (en) Inhibitors of iap
EP2424873A4 (en) NEW GALACTOSID INHIBITORS OF GALECTINES
EP2192838A4 (en) HETEROCYCLIC NEKROPTOSIS HEMMER
SI2205592T1 (sl) Triazoli substituirani s policikličnim arilom in triazoli substituirani s policikličnim heteroarilom uporabni kot Axl inhibitorji
ZA200908919B (en) Pyrazolopyrrolidines as inhibitors of gamma secretase
HK1172326A1 (en) Compounds and compositions and methods of use
ZA201205240B (en) Novel substituted triazole derivatives as gamma secretase modulators
EP2297174A4 (en) EXCLUSIVE SYNTHESIS OF GALACTOSIDE INHIBITORS
HK1156306A1 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases hif--4-
IL212497A0 (en) Heterocyclic gamma secretase modulators
HK1139936A1 (en) Substituted pyrimidodiazepines useful as plk1 inhibitors
HK1158638A1 (en) Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
EP2318395A4 (en) IPA INHIBITORS
IL203797A (en) Benzimidazole and Indole History of Oxadiazole and Oxazole Preserved as 1dgat Inhibitors
ZA201108117B (en) Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
IL208403A0 (en) Compositions and use of epas1 inhibitors
IL209025A0 (en) Urea compounds as gamma secretase modulators
ZA201103738B (en) Lactams as beta secretase inhibitors
ZA201004765B (en) Inhibitors of iap
ZA200808190B (en) Malonamide derivatives as gamma secretase inhibitors
EP2393776A4 (en) NEW TRIFLUOROMETHYLSULFONAMIDE GAMMA SECRETASE HEMMER
IL208916A0 (en) Inhibitors of jnk
EP2273877A4 (en) CYCLOBUTYLSULFONES AS NOTCH-SAVING GAMMA-SECRETASE INHIBITORS
GB0808286D0 (en) Inhibitors of HSP90